Compare Mutual Funds
Bajaj Finserv Healthcare Fund
Select a Mutual Fund
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹500
-
Expense Ratio
2.59
-
NAV
₹11.99
-
Fund Started
06 Dec 2024
-
Fund Size
₹376.77 Cr
-
Exit Load
1% for redemption within 3 Months
-
1 Year
22.24%
-
3 Year
-
-
5 Year
-
-
Equity
96.58%
-
Cash
2.27%
-
Top 10 Holdings
Divi's Laboratories Ltd. | 9.67% |
Sun Pharmaceutical Industries Ltd. | 8.87% |
Piramal Pharma Ltd. | 6.60% |
Apollo Hospitals Enterprise Ltd. | 6.50% |
Aurobindo Pharma Ltd. | 6.13% |
Rubicon Research Ltd. | 6.01% |
Torrent Pharmaceuticals Ltd. | 5.48% |
Neuland Laboratories Ltd. | 4.42% |
Emcure Pharmaceuticals Ltd. | 4.37% |
Max Healthcare Institute Ltd. | 3.80% |
-
Name
-
-
Start Date
-
-
Description
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
-
Launch Date
06 Dec 2024
-
